← Back to Search

Human Papilloma Virus (HPV) Self swab for Human Papillomavirus

N/A
Recruiting
Led By Ann Chang, MD
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after swab is collected
Awards & highlights
No Placebo-Only Group

Summary

In this study, the investigators will assess whether implementing a self-swab protocol for primary Human Papilloma Virus (HPV) testing is an effective method to increase cervical cancer screening in a sample of unscreened women in Hawaii. The findings of this study may support adoption of HPV self swab protocols both at Kalihi Palama Health Center (KPHC) and other Federally Qualified Health Centers (FQHC) in Hawaii.

Eligible Conditions
  • Human Papillomavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after swab is collected
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after swab is collected for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of participants with abnormal result
Percentage of swabs with result
Secondary study objectives
Knowledge of HPV
Knowledge of cervical cancer
Self reported ease of collecting the swab
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Human Papilloma Virus (HPV) Self swabExperimental Treatment1 Intervention
Enrolled participants will be instructed to perform a self swab for genital Human Papilloma Virus (HPV) infection. Additionally, a short survey will be administered to collect demographic information, evaluate knowledge of HPV/cervical cancer, and assess acceptability of HPV self swab.

Find a Location

Who is running the clinical trial?

University of HawaiiLead Sponsor
120 Previous Clinical Trials
55,066 Total Patients Enrolled
Ann Chang, MDPrincipal InvestigatorUniversity of Hawaii
~0 spots leftby Dec 2024